Pharmacokinetic Interaction between Zidovudine and Trimethoprim/sulphamethoxazole in HIV-1 Infected Children

Shannon Dallas; Stanley E Read; Susan King; Gideon Koren; Reina Bendayan

doi:10.1155/2000/640718

Canadian Journal of Infectious Diseases (Jan 2000)

Pharmacokinetic Interaction between Zidovudine and Trimethoprim/sulphamethoxazole in HIV-1 Infected Children

Shannon Dallas,
Stanley E Read,
Susan King,
Gideon Koren,
Reina Bendayan

Affiliations

Shannon Dallas: Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Toronto, Ontario, Canada
Stanley E Read: Department of Pediatrics, Infectious Diseases Division, The Hospital for Sick Children, Toronto, Ontario, Canada
Susan King: Department of Pediatrics, Infectious Diseases Division, The Hospital for Sick Children, Toronto, Ontario, Canada
Gideon Koren: Division of Pharmacology and Toxicology, The Hospital for Sick Children, Toronto, Ontario, Canada
Reina Bendayan: Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Toronto, Ontario, Canada

DOI: https://doi.org/10.1155/2000/640718
Journal volume & issue: Vol. 11, no. 5
pp. 254 – 258

Abstract

Read online

OBJECTIVE: To evaluate the effect of the antimicrobial agent trimethoprim/sulphamethoxazole (TMP/SMX) on the pharmacokinetic properties of the antiretroviral drug zidovudine (ZDV).

Published in Canadian Journal of Infectious Diseases

ISSN: 1180-2332 (Print)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Infectious and parasitic diseases
Website: https://onlinelibrary.wiley.com/journal/9575

About the journal